1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Ludvigsen, S. Kaarsholm, N.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 279 1 7 10.1006/jmbi.1998.1801 9636695 A structural switch in a mutant insulin exposes key residues for receptor binding. 1998 10.2210/pdb1a7f/pdb pdb_00001a7f 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2383.698 INSULIN 1 man polymer 3208.667 INSULIN Y16E, F24G, DEL(T30) 1 man polymer no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A polypeptide(L) no no FVNQHLCGSHLVEALELVCGERGGFYTPK FVNQHLCGSHLVEALELVCGERGGFYTPK B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo baker's yeast Saccharomyces sample 9606 PANCREAS Homo sapiens 4932 Saccharomyces cerevisiae human Homo baker's yeast Saccharomyces sample 9606 PANCREAS Homo sapiens 4932 Saccharomyces cerevisiae database_2 pdbx_database_status pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other 1 0 1998-07-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name _struct_ref_seq_dif.details Y BNL 1998-03-12 REL REL LEAST TOTAL ENERGY (TARGET FUNCTION) 50 20 NOESY DQCOSY TOCSY 8.0 305 K DISTANCE GEOMETRY AND SIMULATED ANNEALING WATER BRUNGER refinement X-PLOR 3.1 structure solution XwinNMR structure solution MNMR structure solution Pronto 600 Bruker AMX600 GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B GLU 16 n 16 GLU 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B GLY 24 n 24 GLY 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ILE 2 -123.80 -50.61 1 A CYS 6 -146.53 43.49 1 A CYS 11 -84.41 -85.76 1 B VAL 2 -165.34 -33.42 1 B ASN 3 -157.88 -42.26 1 B CYS 19 -94.91 -76.37 1 B PRO 28 -62.85 86.88 2 A ILE 2 -137.60 -56.39 2 A GLU 4 -93.02 42.16 2 A ILE 10 -110.99 69.81 2 B GLN 4 -117.66 -84.50 2 B HIS 5 -178.99 -172.53 2 B VAL 18 -55.59 -72.11 2 B CYS 19 -80.68 -74.28 2 B PRO 28 -58.48 -178.75 3 A ILE 2 -163.28 -44.40 3 A CYS 11 -122.58 -160.23 3 A CYS 20 -95.21 36.15 3 B ASN 3 -150.35 22.35 3 B GLN 4 -101.03 -94.54 3 B HIS 5 178.12 168.27 3 B TYR 26 -52.47 108.54 4 A THR 8 -58.66 -82.33 4 A CYS 11 -62.55 -162.32 4 B GLN 4 -99.33 43.53 4 B CYS 7 179.66 142.91 4 B VAL 18 -85.12 -72.03 4 B TYR 26 -58.38 109.13 4 B PRO 28 -52.69 83.96 5 A ILE 2 -167.53 -55.89 5 A SER 9 -109.89 -169.38 5 A CYS 11 -61.95 -174.24 5 B ASN 3 -156.76 34.20 5 B CYS 7 179.61 120.61 5 B ARG 22 -99.86 -64.71 5 B PHE 25 -176.11 -172.02 5 B PRO 28 -57.33 109.94 6 A ILE 2 -141.37 -44.61 6 A CYS 11 -60.19 -169.44 6 A ASN 18 -94.49 32.78 6 B VAL 2 -161.68 -43.81 6 B ASN 3 -156.98 29.16 6 B VAL 18 -87.78 -75.19 6 B CYS 19 -75.74 -76.36 7 A THR 8 -160.95 -42.92 7 A SER 9 -154.06 -125.55 7 A ASN 18 -96.64 37.92 7 B ASN 3 -142.97 30.09 7 B CYS 7 179.67 142.58 7 B CYS 19 -88.68 -70.16 7 B TYR 26 -49.95 101.66 7 B PRO 28 -56.81 105.53 8 A THR 8 -92.64 49.74 8 A CYS 11 -60.40 -178.83 8 A ASN 18 -96.27 30.63 8 B ASN 3 -154.35 24.63 8 B CYS 19 -58.56 -81.14 8 B PHE 25 -176.83 -169.44 8 B TYR 26 -51.52 99.93 9 A THR 8 -129.73 -66.22 9 A CYS 11 -70.69 -167.76 9 A CYS 20 -97.64 33.44 9 B ASN 3 -144.27 30.04 9 B GLN 4 -126.65 -159.50 9 B CYS 19 -79.88 -79.46 9 B PHE 25 -177.72 -177.32 10 A ILE 2 -171.99 -50.03 10 A VAL 3 -92.54 -61.38 10 B ASN 3 -174.40 36.17 10 B CYS 7 178.95 -76.71 10 B TYR 26 -54.50 100.00 10 B PRO 28 -60.49 89.25 11 A ASN 18 -96.89 31.95 11 B ASN 3 -151.57 27.14 11 B GLN 4 -107.24 -97.21 11 B CYS 19 -53.71 -78.83 11 B PHE 25 -178.40 -166.71 11 B TYR 26 -47.29 94.38 12 A GLU 4 -90.52 53.58 12 A GLN 5 -142.22 -46.32 12 A SER 9 -119.62 -167.86 12 A ASN 18 -97.74 35.88 12 B VAL 2 -50.49 172.44 12 B ASN 3 -58.59 92.54 12 B CYS 7 -178.46 127.36 12 B CYS 19 -54.33 -73.29 12 B PHE 25 -179.33 -173.62 12 B TYR 26 -54.46 108.36 13 A CYS 20 -109.31 40.79 13 B ASN 3 0.77 75.82 13 B CYS 7 179.78 105.89 13 B TYR 26 -52.97 95.15 14 A ILE 2 -146.70 -45.27 14 A CYS 7 -93.29 43.74 14 A THR 8 -138.92 -45.22 14 A CYS 11 -62.46 -174.46 14 A ASN 18 -98.53 33.38 14 A CYS 20 -96.47 35.51 14 B ASN 3 -178.84 37.15 14 B CYS 7 179.71 120.25 14 B VAL 18 -86.49 -75.12 14 B PRO 28 -68.35 83.15 15 A ILE 2 -136.90 -48.26 15 A GLN 5 -150.50 -45.96 15 A CYS 11 -82.80 -89.00 15 A ASN 18 -98.02 35.33 15 A CYS 20 -97.97 36.43 15 B VAL 2 -36.07 -72.83 15 B ASN 3 -178.16 54.98 15 B CYS 7 -172.05 120.41 15 B TYR 26 -55.44 93.52 15 B PRO 28 -57.64 -172.34 16 A ILE 2 -143.42 -47.40 16 A GLN 5 -141.20 -50.48 16 A SER 9 -116.98 -162.52 16 A ASN 18 -98.51 32.97 16 B ASN 3 -171.08 40.85 16 B LEU 6 -114.42 55.35 16 B VAL 18 -71.00 -71.76 16 B CYS 19 -68.10 -77.91 17 A ILE 2 -170.73 -53.35 17 B ASN 3 -152.89 29.24 17 B CYS 19 -69.19 -80.24 18 A ILE 2 -172.89 -44.40 18 A SER 9 -117.40 -153.56 18 B ASN 3 -59.44 92.98 18 B CYS 19 -66.43 -74.89 18 B TYR 26 -54.33 109.58 19 A ILE 2 -172.26 -44.74 19 A GLU 4 -90.35 51.72 19 A GLN 5 -138.44 -43.79 19 A THR 8 -99.29 -67.83 19 A CYS 11 -61.74 -178.91 19 A ASN 18 -96.95 33.21 19 A CYS 20 -96.83 40.49 19 B ASN 3 -160.69 31.62 19 B VAL 18 -74.12 -71.21 19 B ARG 22 -91.93 52.70 20 A CYS 11 -68.27 -172.82 20 A CYS 20 -99.31 33.12 20 B VAL 18 -84.77 -73.19 20 B CYS 19 -64.49 -82.51 20 B ARG 22 -93.44 50.74 20 B TYR 26 -57.69 98.85 20 B PRO 28 -59.24 -171.34 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES 1 N N 2 N N A ILE 2 A ILE 2 HELX_P A CYS 7 A CYS 7 1 HE1 6 A LEU 13 A LEU 13 HELX_P A TYR 19 A TYR 19 1 HE2 7 B SER 9 B SER 9 HELX_P B VAL 18 B VAL 18 1 HE3 10 disulf 2.019 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.022 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.019 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 HORMONE HORMONE, HUMAN INSULIN MUTANT, MONOMER, NEUTRAL PH INS_HUMAN UNP 1 90 P01308 INS_HUMAN UNP 2 25 P01308 90 110 1A7F 1 21 P01308 A 1 1 21 25 53 1A7F 1 29 P01308 B 2 1 29 2 TYR engineered mutation GLU 16 1A7F B P01308 UNP 40 16 2 PHE engineered mutation GLY 24 1A7F B P01308 UNP 48 24 1 P 1